AxoGen (AXGN) Competitors

Inspire Medical Systems (NYSE:INSP) and AxoGen (NASDAQ:AXGN) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, risk, earnings, media sentiment, dividends, valuation and profitability.

Do insiders & institutionals believe in INSP or AXGN?

94.9% of Inspire Medical Systems shares are held by institutional investors. Comparatively, 80.3% of AxoGen shares are held by institutional investors. 4.1% of Inspire Medical Systems shares are held by insiders. Comparatively, 2.8% of AxoGen shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Which has more risk and volatility, INSP or AXGN?

Inspire Medical Systems has a beta of 1.22, indicating that its stock price is 22% more volatile than the S&P 500. Comparatively, AxoGen has a beta of 1, indicating that its stock price has a similar volatility profile to the S&P 500.

Do analysts rate INSP or AXGN?

Inspire Medical Systems presently has a consensus target price of $165.62, suggesting a potential upside of 72.88%. AxoGen has a consensus target price of $26.00, suggesting a potential upside of 60.03%. Given Inspire Medical Systems' higher possible upside, equities research analysts plainly believe Inspire Medical Systems is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspire Medical Systems	0 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.54
AxoGen	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media favor INSP or AXGN?

In the previous week, Inspire Medical Systems had 18 more articles in the media than AxoGen. MarketBeat recorded 21 mentions for Inspire Medical Systems and 3 mentions for AxoGen. Inspire Medical Systems' average media sentiment score of 1.08 beat AxoGen's score of 0.79 indicating that Inspire Medical Systems is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspire Medical Systems	13 Very Positive mention(s)	2 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AxoGen	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Which has preferable valuation and earnings, INSP or AXGN?

Inspire Medical Systems has higher revenue and earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspire Medical Systems	$802.80M	3.53	$53.51M	$1.73	55.37
AxoGen	$203.27M	3.68	-$9.96M	-$0.10	-162.47

Is INSP or AXGN more profitable?

Inspire Medical Systems has a net margin of 6.17% compared to AxoGen's net margin of -2.29%. Inspire Medical Systems' return on equity of 10.38% beat AxoGen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspire Medical Systems	6.17%	10.38%	8.93%
AxoGen	-2.29%	-4.43%	-2.34%

Summary

Inspire Medical Systems beats AxoGen on 14 of the 16 factors compared between the two stocks.